Scholars have been building on the work of other scholars, e.g. citing, paraphrasing, building on the ideas of others, for a very long time. This tradition predates copyright, is compatible with All Rights Reserved copyright, and certainly predates Creative Commons licensing, which is only about 15 years old.
Use of ND simply indicates that the author is not granting additional derivative rights. I argue that ND is often in the best interests of advancing our knowledge. For example, one type of derivative that would make sense in the scholarly context is a downstream volunteer co-author, using the original, updating or changing the work, including the original authors and themselves as co-authors. Use of ND is one way to signal to potential downstream volunteer co-authors that this would not be welcome. This is one of the reasons I suggest that OA activists who use or advocate for CC licenses should embrace ND. I also suggest that CC is not the simple solution for OA it appears to be, and I do not recommend paying commercial companies like Elsevier for works to be licensed CC. best, Heather Morrison -------- Original message -------- From: Jevan Pipitone <ema...@jevan.com.au> Date: 2017-06-18 2:00 PM (GMT-05:00) To: "Global Open Access List (Successor of AmSci)" <goal@eprints.org> Subject: Re: [GOAL] Elsevier's interpretation of CC BY-NC-ND Sorry - sending this again - since I forgot to add the list email to it. Re: Creative Commons-Attribution-Noncommercial-No Derivatives (CC-BY-NC-ND) The fact that it says "No Derivatives" seems a concern for example sometimes researchers can publish a summary of other peoples articles and then include all the articles used in the references. But if it says "No Derivatives" does this mean the articles written by other people cannot be used to contribute towards your research, in which case, what is the point in reading them? Also part of the point of reading an article is to gain ideas from other people which can then be used to create new things by the researcher, but, this is potentially a "derivative" work since it can build on the work of others. So I think there is a problem there too. Jevan. On Sun 18-Jun-17 10:29 PM, Richard Poynder wrote: On a related topic, this poster might be of interest to list members: Exploiting Elsevier’s Creative Commons License Requirement to Subvert Embargo "In the last round of author sharing policy revisions, Elsevier created a labyrinthine title-by-title embargo structure requiring embargoes from 12-48 months for author sharing via institutional repository (IR), while permitting immediate sharing via author's personal website or blog. At the same time, all pre-publication versions are to bear a Creative Commons-Attribution-Noncommercial-No Derivatives (CC-BY-NC-ND) license. "At the time this policy was announced, it was rightly criticized by many in the scholarly communication community as overly complicated and unnecessary. However, this CC licensing requirement creates an avenue for subverting the embargo in the IR to achieve quicker open distribution of the author's accepted manuscript. "In short, authors may post an appropriately licensed copy on their personal site, at which point we may deposit without embargo in the IR, not through the license granted in the publication agreement, but through the CC license on the author's version, which the sharing policy mandates. This poster will outline this issue, our experimentation with application, and engage viewers in questions regarding its potential risks, benefits, and workflows." https://kuscholarworks.ku.edu/handle/1808/24107 On 18 June 2017 at 12:24, Mittermaier, Bernhard <b.mitterma...@fz-juelich.de<mailto:b.mitterma...@fz-juelich.de>> wrote: Dear colleagues, on sharing in file-sharing networks, Creatice Commons explain: “Can I share CC-licensed material on file-sharing networks? Yes. All CC licenses allow redistribution of the unmodified material by any means, including distribution via file-sharing networks. Note that file-trading is expressly considered to be noncommercial for purposes of compliance with the NC licenses. Barter of NC-licensed material for other items of value is not permitted.” https://creativecommons.org/faq/#can-i-share-cc-licensed-material-on-file-sharing-networks The “Elsevier Sharing Rules” say “CC-BY-NC-ND licensed articles may be shared on non-commercial platforms only.” http://help.sciencedirect.com/flare/sdhelp_Left.htm#CSHID=password.htm|StartTopic=Content%2Fsharing_pubs.htm|SkinName=svs_SD<http://help.sciencedirect.com/flare/sdhelp_Left.htm#CSHID=password.htm%7CStartTopic=Content%2Fsharing_pubs.htm%7CSkinName=svs_SD> and again in the table at the bottom of that webpage: “Public posting on commercial platforms (e.g., www.researchgate.net<http://www.researchgate.net>, www.academia.edu<http://www.academia.edu>)” :not allowed I’ve been asking Alicia Wise, on what grounds why Elsevier takes that position. She replied: „Both ResearchGate & academia.edu<http://academia.edu> use content commercially to sell advertising & services around the content they disseminate” and “Both ResearchGate & academia.edu<https://t.co/IQgdiiCF1s> are problems in Germany as they go beyond private use to make NC content publicly available” (https://twitter.com/wisealic/status/874284792275140609 and https://twitter.com/wisealic/status/874284916644696066 ) My interpretation of the CC licence is that sharing of CC BY-NC-ND article by commercial platforms is OK as long as they don’t sell the articles (which they don’t do). But apart from that - what authors are doing is IMHO definitely not prohibited because they have no commercial gain whatsoever. What do you think? Kind regards Bernhard ########################################### Dr. Bernhard Mittermaier Forschungszentrum Jülich GmbH Leiter der Zentralbibliothek / Head of the Central Library 52425 Jülich Tel ++49-2461-613013<tel:+49%202461%20613013> Fax ++49-2461-616103<tel:+49%202461%20616103> Sitz der Gesellschaft: Juelich Eingetragen im Handelsregister des Amtsgerichts Dueren Nr. HR B 3498 Vorsitzender des Aufsichtsrats: MinDir Dr. Karl Eugen Huthmacher Geschaeftsfuehrung: Prof. Dr.-Ing. Wolfgang Marquardt (Vorsitzender), Karsten Beneke (stellv. Vorsitzender), Prof. Dr.-Ing. Harald Bolt, Prof. Dr. Sebastian M. Schmidt _______________________________________________ GOAL mailing list GOAL@eprints.org<mailto:GOAL@eprints.org> http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal -- Richard Poynder www.richardpoynder.co.uk<http://www.richardpoynder.co.uk> _______________________________________________ GOAL mailing list GOAL@eprints.org<mailto:GOAL@eprints.org> http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal -- [cid:part16.DB548166.99BE7686@jevan.com.au] [cid:part17.D8019FCC.00531A40@jevan.com.au] Jevan Pipitone MIT SE (UC), GradDip IT (UC), BSc (ANU), GradCert Rsch Methods & Des (UC) C#.NET/VB.NET Developer, ASP.NET MySql/MS Sql C#/VB Database Driven Websites, IT Research, IT Support, IT Tutoring http://www.jevan.com.au/ ema...@jevan.com.au<mailto:ema...@jevan.com.au> Tel: (02) 6176 1285 / 0498 627 366 (+612 6176 1285 / +61 498 627 366) Skype: jevanp Canberra, Australia [cid:part20.39B9650A.32200250@jevan.com.au] [http://ts.msgtag.net/bf/lxktztyh/yyyDD/ddrBbuDniaoAFpxvn.gif]
_______________________________________________ GOAL mailing list GOAL@eprints.org http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal
